Information:
Error:
Keywords
Pharmacokinetics ×
- Clinical Trial (259)
- Clinical Trial, Phase I (96)
- Vital Signs (84)
- Laboratories (70)
- Electrocardiogram (ECG) (59)
- Drugs, Investigational (58)
- Blood (58)
- Diabetes Mellitus, Type 2 (54)
- Hypertension (43)
- Adverse event (37)
- On-Study Form (35)
- Purpura, Thrombocytopenic, Idiopathic (30)
- Cross-Over Studies (29)
- Child (29)
- Stroke (24)
- Liver (24)
- Clinical Chemistry Tests (23)
- Contraceptives, Oral, Combined (23)
- Pulmonary Disease, Chronic Obstructive (20)
- Concomitant Medication (19)
- Type 2 Diabetes (19)
- Blood Glucose (18)
- Blood Pressure (17)
- End of Study (16)
- Endocrinology (16)
- Migraine Disorders (16)
- Drug trial (14)
- Hematology (14)
- Alcohol Drinking (13)
- Randomized Controlled Trial (12)
- Sumatriptan (12)
- Testosterone (11)
- Urinalysis (11)
- Drug-Related Side Effects and Adverse Reactions (11)
- Diagnostic Imaging (11)
- Hypogonadism (11)
- Atherosclerosis (10)
- Double-Blind Method (10)
- Respiratory Function Tests (9)
- Telemetry (9)
- Pulmonary Medicine (9)
- Biopsy (9)
- Hypereosinophilic Syndrome (9)
- Depressive Disorder (9)
- Neurology (9)
- Pregnancy (8)
- Arthritis, Rheumatoid (8)
- Physical Examination (7)
- Psychiatry (7)
- Rhinitis (7)
- Urine (7)
- Parkinsons Disease (7)
- Rhinitis, Allergic, Perennial (6)
- Clinical Trial, Phase III (6)
- Treatment Form (6)
- Glucose Tolerance Test (6)
- Gynecology (6)
- Hematologic Tests (6)
- Hypoglycemic Agents (6)
- Laboratories, Hospital (6)
- Pharmacogenetics (5)
- Placebos (5)
- Signs and Symptoms (5)
- Receptors, Tumor Necrosis Factor, Type I (5)
- Nasal Sprays (5)
- Eligibility Determination (5)
- Follow-Up Studies (5)
- Medical Records (5)
- Random Allocation (4)
- Asthma (4)
- Substance Abuse Detection (4)
- Clinical Trial, Phase II (4)
- Fructosamine (4)
- Breast Neoplasms (4)
- Clinical Laboratory Services (4)
- Demography (4)
- Drug Administration Schedule (4)
- Anxiety Disorders (4)
- Restless Legs Syndrome (3)
- Visual Acuity (3)
- Women (3)
- Substance-Related Disorders (3)
- Urine Specimen Collection (3)
- Premature Ejaculation (3)
- Healthy Volunteers (3)
- Coronary Disease (3)
- Drug Therapy (3)
- Eating (3)
- Electrocardiography (3)
- Endocrine System (3)
- Eye Diseases (3)
- Heart Rate (3)
- Liver Diseases (3)
- Macular Degeneration (3)
- Multiple Sclerosis (3)
- Office Visits (3)
- Peak Expiratory Flow Rate (3)
- Pregnancy Tests (2)
- Prostatic Hyperplasia (2)
Table of contents
Selected data models
You must log in to select data models for download or further analysis.
329 Search results.
Itemgroups: Administrative,Vital Signs,12-Lead ECG,Laboratory Results Data (Haematology) - Pre-Dose,Laboratory Results Data (Clinical Chemistry) - Pre-Dose,Urinalysis - Pre-Dose,Randomisation Number,Investigational Product,Treatment Confirmation,PET Scan (2),fMRI Scan - Post-PET Scan,PET Scan (3),Pharmacokinetics - Blood,Laboratory Results Data (Haematology) - 24hrs Post-Dose,Laboratory Result Data (Clinical Chemistry) - 24hrs Post-Dose,Urinalysis - 24hrs Post-Dose
Itemgroups: Administrative Data,Dosing date and time,PK Blood Sample
Itemgroups: Local Laboratory,Urinalysis | Local,Vital signs,12 lead ECG,Electrocardiogram abnormal,Drug Kinetics; Blood,12 lead ECG | Holter Electrocardiography | Summary Report,Holter Electrocardiography | Electrocardiogram abnormal | Summary Report
Itemgroups: Administration,Demographic Details,Volunteer Inclusion Criteria,Volunteer Exclusion Criteria,Infusion Details,ECG-Arrhythmia,Electrocardiography,Electrocardiography,Alcohol Screening (Blow test),Drug Screening (Urine),Baseline Events,Baseline Events,Adverse Events,Adverse Events
Itemgroups: Administration,Glucose Assay,Glucose Assay,Plasma Drug Assay,Plasma Drug Assay,Volunteer Completion/Withdrawal,Investigator's checklist,Investigator's Statement,Concominant Medication,Missing Data,Missing Data,Missing Data,Missing Data
Itemgroups: Administrative Data,Eligibility question,Inclusion Criteria,Exclusion Criteria
Itemgroup: PK Dosing
Itemgroups: Note,Inclusion Criteria,Exclusion Criteria,Physical examination,Pregnancy test,Alcohol test,Urine drug screening,orthostatic blood pressure / Pulse - Predose,Concomitant medication,Adverse event,Patient diary,Randomization,High fat breakfast,Study Drug Dosing,Orthostatic blood pressure / pulse measurement - post dose,Adverse Event - post dosing,Pharmacokinetic sampling post dosing,Discharge
Itemgroups: Date of Visit,Summary Holter,Summary Holter Abnormalities,Electroniclly Transferred Lab Data - Dosing Date and Time,Electronically Transerred Lab Data - Pre-dose,Electronically Transerred Lab Data - 1 Hour,Electronically Transerred Lab Data - 2 Hour ,Electronically Transerred Lab Data - 4 Hour,Electronically Transerred Lab Data - 8 Hour ,Electronically Transerred Lab Data - 24 Hour,Electronically Transerred Lab Data - 36 Hour ,Electronically Transerred Lab Data - 48 Hour,Electronically Transerred Lab Data - 72 Hour ,Pharmacokinetics Blood,Pharmacokinetics Blood - Extra Scheduled Samples Entry ,Urinalysis - Dosing Date and Time ,Urinalysis Dipstick Details - Pre-Dose,Urinalysis Dipstick Details - 2 Hour Post-Dose,Urinalysis Dipstick Details - 4 Hour Post-Dose ,Urinalysis Dipstick Details - 8 Hour Post-Dose ,Urinalysis Dipstick Details - 24 Hour Post-Dose ,Urinalysis Dipstick Details -36 Hour Post-Dose,Urinalysis Dipstick Details -48 Hour Post-Dose ,Urinalysis - Local: Microscopy Details
Itemgroup: Pharmacokinetics
Itemgroups: Inclusion Criteria,Exclusion Criteria
Itemgroups: Administrative Data,12-Lead ECG Abnormalities,Rhythm,P-Wave Morphology,Conduction,Myocardial Infarction,Depolarisation/Repolarisation (QRS-T),ECG, Other abnormalities